Back to top
more

Virtus LifeSci Biotech Clinical Trials ETF: (BBC)

(Delayed Data from NYSE) As of Jul 16, 2025 03:59 PM ET

$21.44 USD

21.44
12,061

+0.38 (1.78%)

Volume: 12,061

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $21.60 +0.16 (0.75 %) 7:58 PM ET

Zacks News

Sanghamitra Saha headshot

Beyond Biotech, 5 ETFs Up At Least 10% in Q4

Apart from biotech, these ETFs are seeing solid momentum in the ongoing quarter.

Neena Mishra headshot

Why Biotech ETFs are Surging to New Highs

increasing M&A deals and cutting edge therapies are driving biotech ETFs higher

Sweta Killa headshot

Biotech ETFs Hit New Highs on Deal Activities

Following the new deals in the healthcare space, a few biotech ETFs hit new highs.

Sweta Killa headshot

Biotech ETF (BBC) Hits a New 52-Week High

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

Sanghamitra Saha headshot

Top ETF Stories of November

Inside the key ETF events of the month of November.

Sweta Killa headshot

Top & Flop ETFs of November

November was kind to the stock market with major bourses logging the best monthly gain since June.

Sweta Killa headshot

Biotech Tops in November: Best ETFs & Stocks

The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.

Sanghamitra Saha headshot

Top and Flop ETFs of Last Week

Last week was downbeat for the broader market owing to uncertainty over the signing of the ???phase-one??? trade deal between the United States and China.

Sweta Killa headshot

Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD

Healthcare bounced back with an outperformance starting the fourth quarter.

Sweta Killa headshot

S&P 500 at Record High: 6 ETF Winners of Last Week

The S&P 500 hit record highs last week, with the index rising for the fourth consecutive week, marking its longest winning streak since March.

Sweta Killa headshot

Healthcare ETFs Win in October: Here's Why

The healthcare sector, which has been the second-worst performer among the 11 major S&P 500 sectors this year, took the center stage this month with some outperformance compared to other sectors.

Sweta Killa headshot

Biotech ETFs Surge on a Flurry of Positive News

The biotech sector got a boost over the past week from a flurry of positive news including trial results and deal activities.

Sweta Killa headshot

Trump Proposes 2020 Budget: ETFs to Top & Flop

Here are the key takeaways from the proposed 2020 budget and their expected impact on ETFs.

Sanghamitra Saha headshot

6 Wining ETF Areas From a Late Santa Rally

These sector ETFs have made the most of the start of this Santa Rally.

Sanghamitra Saha headshot

4 Worst ETF Areas of Q4

These ETF areas have been particularly painful in the bloodbath of the fourth quarter.

Sweta Killa headshot

Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?

Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.

Sweta Killa headshot

Top and Flop ETFs at Half-Way Q4

We have highlighted both the best and worst performing zones and their ETFs at halfway Q4.

Sanghamitra Saha headshot

ETF Areas That Spooked Investors in October

These ETF areas lost the most in the Halloween month and gave investors the chills.

Sanghamitra Saha headshot

Scared of a September Lull? Play 6 ETFs

These ETFs may perform well in ill-famed September due to solid fundamentals.

    Sanghamitra Saha headshot

    5 ETFs to Play in July

    Investors may tap these five ETFs for gains as President Trump aims the first shot in the trade war.

      Sweta Killa headshot

      5 Safe and Sound ETF Strategies for 2H

      After a bumpy ride in the first half of the year, global stocks are bouncing back despite the trade war fears.

        Sweta Killa headshot

        How to Build a Winning ETF Portfolio Amid Trade War Fears

        We have highlighted some strategies that could prove extremely beneficial for investors in a choppy market.

          Sweta Killa headshot

          Sarepta Pharma Pushes Two Biotech ETFs to New Highs

          The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

            Neena Mishra headshot

            Why These Small Cap Biotech ETFs are Soaring

            These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

              Sweta Killa headshot

              Best and Worst ETFs of Last Week

              Several ETFs saw a huge decline while a few stood tall in the market turbulence.